Wells Fargo’s Maze Therapeutics, Inc. Common Stock MAZE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$68.9K Buy
5,615
+922
+20% +$11.3K ﹤0.01% 4977
2025
Q1
$51.7K Buy
+4,693
New +$51.7K ﹤0.01% 4934